Myomo Inc. (MYO)
NYSE: MYOHealthcareMedical DevicesUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
MYO stock chart
Technical analysisKey statistics
All statistics- Market cap
- $55.85M
- EPS (TTM)
- -$0.35
- Dividend yield
- None
- 52-week range
- 0.605 – 1.89
- Day range
- 1.38 – 1.47
- Volume / Avg
- 232.15K / 495.87K
- Beta
- —
- Shares outstanding
- 39.61M
52-week range
MYO stock today
Myomo (MYO) closed at $1.41 on Oct 8, down 2.76% (-$0.04), versus the S&P 500's 0.47% decline. Trading was light, with 232.15K shares changing hands, about 47% of the average daily volume. Shares are 25.2% below their 52-week high of $1.89, set on Aug 19, 2026 and 133.1% above the 52-week low of $0.605, in the middle of the past year's range.
MYO is up 54.9% year to date, outperforming the S&P 500 (+13.5%). Over the past 12 months, the stock has gained 19.5%. Myomo has posted a net loss over the last twelve months (EPS of -$0.35), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About Myomo
Company profileMyomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. It also provides MyoPro 2 that includes control technology, configuration software and user interface, and pop-out battery for extended use of the brace; MyoPro2+, which comprises 3D printed orthotics capability, software enhancements, and a design for donning and doffing of the device; MyoGames, a virtual training platform; and MyoPro 2x Video Library.
- Sector
- Healthcare
- Industry
- Medical Devices
- CEO
- Mr. Paul R. Gudonis
- Headquarters
- Burlington, MA
- Employees
- 194
- IPO year
- 2017
- Website
- myomo.com
Analyst forecast
ForecastConsensus (5 analysts)
none
Avg. price target
$4.64+229.08%
- Strong buy 1
- Buy 4
- Hold 0
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Myomo peers
Healthcare sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| MDAISpectral AI Inc. Class A | 1.64 | 0.00% | $52.78M | vs MYO |
| COCHEnvoy Medical Inc. Class A | 0.6576 | +0.61% | $50.76M | vs MYO |
| SNWVSANUWAVE Health Inc. | 5.85 | +5.51% | $50.28M | vs MYO |
| SRTSSensus Healthcare Inc. | 2.97 | +1.02% | $48.89M | vs MYO |
| TELATELA Bio Inc. | 1.05 | -1.87% | $47.40M | vs MYO |
| XTNTXtant Medical Holdings Inc. | 0.321 | -0.16% | $45.03M | vs MYO |
| CVRXCVRx Inc. | 1.68 | +0.60% | $44.76M | vs MYO |
| NNOXNANO-X IMAGING LTD | 0.5663 | -4.82% | $44.50M | vs MYO |
Indexes, lists and sector
Appears in lists
Myomo stock FAQ
What is Myomo's stock price today?
MYO last traded at $1.41 as of Oct 8, 4:00 PM EDT, down 2.76% on the day. Prices are delayed at least 15 minutes.
Does Myomo pay a dividend?
No. Myomo does not currently pay a regular cash dividend.
Who is Myomo's CEO?
Mr. Paul R. Gudonis is the chief executive officer of Myomo Inc., which has about 194 employees.
Has MYO ever split its stock?
Yes. The most recent MYO stock split was a 1-for-30 split on Jan 31, 2020.
What is the MYO 52-week high?
The 52-week high for MYO is $1.89 and the 52-week low is $0.605. The stock is currently 25.2% below its high.